Softwr

Healthcare · head to head

Ibex Medical Analytics vs SilverCloud by Amwell

Ibex Medical Analytics logo

Ibex Medical Analytics

Healthcare

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

From
On request
Rated
-
SilverCloud by Amwell logo

SilverCloud by Amwell

Healthcare

Guided digital cognitive behavioural therapy with a published randomised trial evidence base

From
On request
Rated
-

The short version

  • Each has a real cost: Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.; SilverCloud by Amwell the evidence base is for the guided model, and organisations that deploy SilverCloud as unstaffed self service get the completion rates of unguided self help, which is not what the trials measured.
  • They diverge on capability: Ibex Medical Analytics covers Ibex Breast Suite, SilverCloud by Amwell covers Guided programmes.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ibex Medical Analytics and SilverCloud by Amwell actually diverge.

Attributes where Ibex Medical Analytics and SilverCloud by Amwell differ
AttributeIbex Medical AnalyticsSilverCloud by Amwell
PlatformsWeb, Cloud, On-premiseWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ibex Medical Analytics

  • Ibex Breast Suite
  • Ibex Prostate
  • Ibex Gastric
  • Second read safety net
  • Prescreening triage
  • Heatmap localisation
  • Quality reporting
  • Scanner-agnostic ingestion

Only in SilverCloud by Amwell

  • Guided programmes
  • Supporter review
  • Symptom measurement
  • Clinician dashboard
  • Risk detection
  • NHS talking therapies alignment
  • Multiple deployment models

What people use each for

The jobs each tool is most often brought in to do.

Ibex Medical Analytics

  • A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot SilverCloud by Amwell
  • A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot SilverCloud by Amwell
  • A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot SilverCloud by Amwell
  • A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot SilverCloud by Amwell

SilverCloud by Amwell

  • An NHS talking therapies service needing a digital option that fits national reporting requirements and reduces waiting list pressure for step two interventionsnot Ibex Medical Analytics
  • A health plan wanting a digital mental health offering it can defend to a clinical governance committee with peer reviewed trial evidencenot Ibex Medical Analytics
  • A university counselling service facing demand it cannot staff, using guided digital cognitive behavioural therapy as a first stepnot Ibex Medical Analytics
  • An employer that wants an evidence based clinical intervention rather than a wellbeing content librarynot Ibex Medical Analytics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ibex Medical Analytics

  • The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
  • Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
  • Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
  • Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

SilverCloud by Amwell

  • The evidence base is for the guided model, and organisations that deploy SilverCloud as unstaffed self service get the completion rates of unguided self help, which is not what the trials measured.
  • Supporter capacity is normally the buyer responsibility rather than part of the licence, so the real cost includes trained staff time that does not appear on the software quote.
  • Digital cognitive behavioural therapy has substantial dropout across all vendors, so a service planning capacity from enrolment numbers rather than completion numbers will overstate the throughput gained.
  • It is now sold as part of the Amwell portfolio, and Amwell has restructured its product lines since acquiring SilverCloud, so buyers should ask how SilverCloud is positioned within the Amwell Converge platform and whether it can still be bought standalone.
  • Guided digital cognitive behavioural therapy is a step two intervention and does not serve moderate to severe presentations, so a service that buys it without a funded escalation pathway simply relocates the queue.

Pricing, plan by plan

Ibex Medical Analytics

On request
  • Ibex clinical applications$undefined/year
    • Priced per case analysed under an annual agreement
    • Breast, prostate and gastric licensed as separate suites
    • Regulatory indication differs between Europe and the United States

SilverCloud by Amwell

On request
  • SilverCloud by Amwell$undefined/year
    • Priced per member per month or per completed course depending on the buyer type
    • Supporter capacity is usually provided by the buyer, not included in the licence
    • Programme library scope affects the rate

Which should you pick?

Choose Ibex Medical Analytics if

  • You need ibex breast suite.
  • You work on Web, Cloud, On-premise.
  • You also want ibex prostate.

Choose SilverCloud by Amwell if

  • You need guided programmes.
  • You work on Web, iOS, Android.
  • You also want supporter review.

Questions people ask

Is Ibex Medical Analytics or SilverCloud by Amwell better?
Neither clearly leads. Ibex Medical Analytics starts at On request and SilverCloud by Amwell at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ibex Medical Analytics or SilverCloud by Amwell?
Ibex Medical Analytics starts at On request and SilverCloud by Amwell at On request.
Does Ibex Medical Analytics or SilverCloud by Amwell run on more platforms?
Ibex Medical Analytics runs on Web, Cloud, On-premise. SilverCloud by Amwell runs on Web, iOS, Android.
What is Ibex Medical Analytics best used for?
Ibex Medical Analytics is most often used for a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out, a private laboratory group standardising gleason grading across pathologists with known interobserver variability, a service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its board, a gastrointestinal service wanting helicobacter pylori detection automated so pathologists spend their time on the neoplastic cases. Of those, a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out and a private laboratory group standardising gleason grading across pathologists with known interobserver variability are not what SilverCloud by Amwell is typically brought in for.
What can Ibex Medical Analytics do that SilverCloud by Amwell cannot?
Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net. SilverCloud by Amwell covers Guided programmes, Supporter review, Symptom measurement, Clinician dashboard.

Answered from the vendors’ own pages

Ibex Medical Analytics: Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

SilverCloud by Amwell: Is SilverCloud still available under its own name?

Yes. It is marketed as SilverCloud by Amwell and has its own product pages and NHS partnership, though contracting runs through Amwell.

Ibex Medical Analytics: Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

SilverCloud by Amwell: What evidence supports it?

It has been evaluated in independently led randomised controlled trials, including a National Institute of Mental Health funded study published in Nature Human Behaviour in 2026 examining prevalence of mental disorders over two years at scale.

Ibex Medical Analytics: Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

SilverCloud by Amwell: Do we need to provide the supporters?

In most deployments, yes. The guided model requires trained supporter time, and that staffing is usually the buyer responsibility rather than included in the licence.

Ibex Medical Analytics: What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

SilverCloud by Amwell: Is it suitable for severe presentations?

No. It is a step two style intervention for mild to moderate presentations, and it needs a funded escalation pathway for anything more severe.

Share

Related pages

Other head to heads